Analyst Price Targets — CALA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 15, 2022 4:04 am | — | Leerink Partners | $2.00 | $2.82 | Benzinga | SVB Leerink Downgrades Calithera Biosciences to Market Perform, Lowers Price Target to $2 |
Latest News for CALA
Calithera Biosciences, Inc. (NASDAQ: CALA - Get Free Report)'s share price passed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $0.00 and traded as high as $0.0001. Calithera Biosciences shares last traded at $0.0001, with a volume of 887 shares changing hands. Calithera Biosciences
Institutional and Insider Ownership 0.1% of Merck KGaA shares are held by institutional investors. 6.6% of Calithera Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Earnings and Valuation This table compares Calithera Biosciences and
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CALA.
U.S. House Trading
No House trades found for CALA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.